A local anesthetic
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Product Categories

Product Type

Pramoxine (hydrochloride)

Item No. 30077

Technical Information
Formal Name
4-[3-(4-butoxyphenoxy)propyl]-morpholine, monohydrochloride
CAS Number
637-58-1
Synonyms
  • Pramocaine
Molecular Formula
C17H27NO3 • HCl
Formula Weight
Purity
≥98%
A solid
DMF: 5mg/mLDMSO: 5mg/mLEthanol: 15mg/mLEthanol:PBS (pH 7.2) (1:5): 0.16mg/mL
λmax
227 nm
SMILES
CCCCOC1=CC=C(OCCCN2CCOCC2)C=C1.Cl
InChi Code
InChI=1S/C17H27NO3.ClH/c1-2-3-12-20-16-5-7-17(8-6-16)21-13-4-9-18-10-14-19-15-11-18;/h5-8H,2-4,9-15H2,1H3;1H
InChi Key
SYCBXBCPLUFJID-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    Pramoxine is a local anesthetic.1 It reduces electrically induced peak compound action potential (CAP) amplitudes in isolated frog sciatic nerve (IC50 = 0.21 mM).2 Topical administration of pramoxine (0.35 and 0.6%) inhibits winking in a rabbit corneal test, indicating anesthetic activity.1 It inhibits the pinprick-induced cutaneous trunci muscle reflex (CTMR) in the skin of rats (ED50 = 42.1 μmol, s.c.).3

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Schmidt, J.L., Blockus, L.E., and Richards, R.K. The pharmacology of pramoxine hydrochloride: A new topical local anesthetic. Curr. Res. Anesth. Analg. 32(6:1), 418-425 (1953).

    2. Hirao, R., Fujita, T., Sakai, A., et alCompound action potential inhibition produced by various antidepressants in the frog sciatic nerve. Eur. J. Pharmacol. 819, 122-128 (2018).

    3. Chou, A.-K., Chiu, C.-C., Chen, Y.-W., et alSkin nociceptive block with pramoxine delivery by subcutaneous injection in rats. Pharmacol. Rep. 70(6), 1180-1184 (2018).